2,3-dinor-thromboxane b2 has been researched along with Multiple Sclerosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brunkhorst, R; Förstermann, U; Frei, U; Frölich, JC; Gréen, K; Haas, J; Koch, KM; Kühn, K; Vesterqvist, O | 1 |
1 other study(ies) available for 2,3-dinor-thromboxane b2 and Multiple Sclerosis
| Article | Year |
|---|---|
An increase in the ratio of thromboxane A2 to prostacyclin in association with increased blood pressure in patients on cyclosporine A.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Cyclosporins; Epoprostenol; Female; Humans; Hypertension; Male; Multiple Sclerosis; Thromboxane A2; Thromboxane B2 | 1989 |